Li, J., Wang, S., Wang, Y., Wang, X., Wang, H., Feng, J., . . . Jiang, Z. (2017). Disparities of Trastuzumab Use in Resource‐Limited or Resource‐Abundant Regions and Its Survival Benefit on HER2 Positive Breast Cancer: A Real‐World Study from China. Oncologist.
Dyfyniad Arddull ChicagoLi, Jianbin, et al. "Disparities of Trastuzumab Use in Resource‐Limited or Resource‐Abundant Regions and Its Survival Benefit On HER2 Positive Breast Cancer: A Real‐World Study From China." Oncologist 2017.
Dyfyniad MLALi, Jianbin, et al. "Disparities of Trastuzumab Use in Resource‐Limited or Resource‐Abundant Regions and Its Survival Benefit On HER2 Positive Breast Cancer: A Real‐World Study From China." Oncologist 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.